Published guidance, NICE advice and quality standards | Guidance

Showing 331 to 340 of 875

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Tepotinib for treating advanced non-small-cell lung cancer with MET gene alterations	TA789	18 May 2022	18 May 2022
Avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapy	TA788	11 May 2022	11 May 2022
Tucatinib with trastuzumab and capecitabine for treating HER2-positive advanced breast cancer after 2 or more anti-HER2 therapies	TA786	27 April 2022	27 April 2022
Venetoclax with low dose cytarabine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable	TA787	27 April 2022	27 April 2022
Niraparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancer	TA784	20 April 2022	20 April 2022
Nivolumab with cabozantinib for untreated advanced renal cell carcinoma (terminated appraisal)	TA785	20 April 2022	20 April 2022
Daratumumab monotherapy for treating relapsed and refractory multiple myeloma	TA783	13 April 2022	13 April 2022
Sotorasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer	TA781	30 March 2022	30 March 2022
Tagraxofusp for treating blastic plasmacytoid dendritic cell neoplasm (terminated appraisal)	TA782	30 March 2022	30 March 2022
Nivolumab with ipilimumab for untreated advanced renal cell carcinoma	TA780	24 March 2022	24 March 2022